Tag: neuromodulation therapy

PathMaker initiates US multicentre trial evaluating non-invasive post-stroke spasticity treatment

PathMaker Neurosystems has announced initiation of its US multicentre clinical trial to evaluate MyoRegulator for the non-invasive treatment of post-stroke upper-limb spasticity. The trial is...

AI, cost reductions and more represent bright future for neuromodulation industry

On technological and commercial fronts alike, the neuromodulation space is one of the more rapidly evolving subsectors within the medical industry—and has undergone a...

Researchers pave way for adaptive DBS treatment after identifying OCD-associated brain...

In an effort to improve treatment for obsessive-compulsive disorder (OCD), a team of researchers has—for the first time, according to a Brown University (Providence,...

Salim Hayek

Salim Hayek is chief of the Division of Pain Medicine at University Hospitals of Cleveland and a professor in Case Western Reserve University’s Department...

NIH launches first phase of US$9.8 million competition to accelerate development...

The National Institutes of Health (NIH) has launched the first phase of the Neuromod Prize—a US$9.8 million competition to accelerate the development of neuromodulation therapies....
telehealth neuromodulation

NANS 2022: Telehealth to play key role in improving patient access...

COVID-19 may have held a defining role in the “rebirth” of telehealth and remote care models in the USA, but their utility in improving...
saint depression treatment

Novel neuromodulation technique could be “gamechanger” in treatment-resistant depression

Stanford accelerated intelligent neuromodulation therapy (SAINT)—a novel, high-dose intermittent theta-burst stimulation (iTBS)—was found to be safe and more effective than sham stimulation in a...